| Product NDC: | 24987-435 |
| Proprietary Name: | FORTAZ |
| Non Proprietary Name: | ceftazidime |
| Active Ingredient(s): | 111 mg/mL & nbsp; ceftazidime |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 24987-435 |
| Labeler Name: | Covis Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050578 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121214 |
| Package NDC: | 24987-435-00 |
| Package Description: | 10 VIAL in 1 TRAY (24987-435-00) > 18 mL in 1 VIAL |
| NDC Code | 24987-435-00 |
| Proprietary Name | FORTAZ |
| Package Description | 10 VIAL in 1 TRAY (24987-435-00) > 18 mL in 1 VIAL |
| Product NDC | 24987-435 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ceftazidime |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20121214 |
| Marketing Category Name | NDA |
| Labeler Name | Covis Pharmaceuticals, Inc. |
| Substance Name | CEFTAZIDIME |
| Strength Number | 111 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |